CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Bloodworks Northwest

Academic/Hospital

Also known as: Bloodworks | Bloodworks Northwest

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

First marketed drug

Last known activity

Feb 1, 2022

Timeline

2010s

Jan 28, 2016
allogeneic hematopoietic stem cells— NDA Secondary Org

Drugs by trial phase (4 distinct, 3 trials)

Phase 2 (4 own, 0 via acquisition)

Indications

Studied for

Blood Platelet Disorders

Marketed drugs (1)

allogeneic hematopoietic stem cells

Recent trials (7)

NCT05220787Sponsor investigatorPhase 1/Phase 2Feb 1, 2022
NCT05220787Lead sponsorPhase 1/Phase 2Feb 1, 2022
NCT05220787Overall official - principal investigatorPhase 1/Phase 2Feb 1, 2022
NCT05111028Overall official - principal investigatorPhase 1/Phase 2Nov 20, 2020
NCT05111028Lead sponsorPhase 1/Phase 2Nov 20, 2020
NCT03787927Overall official - principal investigatorPhase 1/Phase 2Dec 3, 2018
NCT03787927Lead sponsorPhase 1/Phase 2Dec 3, 2018

Details

Last known activity: Feb 1, 2022